Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.

Molecular diagnosis & therapy - 1 Feb 2014

Ismail Ashrafali Mohamed, Samuel Prasanna, Ramachandran Jeyamani, Eapen Chundamannil Eapen, Kannangai Rajesh, Abraham Priya

Abstract excerpt

BACKGROUND AND OBJECTIVE: Management of chronic hepatitis B is a global public health challenge. There are several updated guidelines proposed based on treatment outcome data from the respective study populations. In this study, we aim to characterize the antiviral resistance mutations to lamivud...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Lamivudine

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 24030850
DOI: 10.1007/s40291-013-0054-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24030850-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lamivudine monotherapy in chronic hepatitis B patients from the Indian subcontinent: antiviral resistance mutations and predictive factors of treatment response.PMID 24030850Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.Semantic proximity Read ↗

Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies.Semantic proximity Read ↗

Viral resistance in hepatitis B: prevalence and management.Semantic proximity Read ↗

Evaluation of genotype characteristics and drug resistance mutations in patients with chronic hepatitis B.Semantic proximity Read ↗

Evaluation of genotype characteristics and drug resistance mutations in patients with chronic hepatitis BSemantic proximity Read ↗

Chronic hepatitis B: preventing, detecting, and managing viral resistance.Semantic proximity Read ↗

Hepatitis B virus subtypes and lamivudine resistance.Semantic proximity Read ↗

Lamivudine resistance in untreated chronic hepatitis B patients in Turkey.Semantic proximity Read ↗

Comprehensive Analysis of Clinically Significant Hepatitis B Virus Mutations in Relation to Genotype, Subgenotype and Geographic RegionSemantic proximity Read ↗

Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.Semantic proximity Read ↗

Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002-2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.